Moderna
MRNA
#1830
Rank
ยฃ8.12 B
Marketcap
ยฃ20.79
Share price
8.67%
Change (1 day)
-38.21%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -ยฃ2.42 Billion

According to Moderna 's latest financial reports the company's current earnings are ยฃ2.20 Billion. In 2024 the company made an earning of -ยฃ2.69 Billion, an increase over its 2023 earnings that were of -ยฃ2.94 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ2.42 Billion-10.09%
2024 -ยฃ2.69 Billion-8.22%
2023 -ยฃ2.94 Billion-140.65%
2022 ยฃ7.20 B-27.81%
2021 ยฃ9.98 B-1911.15%
2020 -ยฃ0.56 Billion44.7%
2019 -ยฃ0.39 Billion28.63%
2018 -ยฃ0.3 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regulus Therapeutics
RGLS
-ยฃ35.61 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ17.33 B-834.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ31.35 Million-98.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ97.82 M-104.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ12.32 B-622.07%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
-ยฃ56.36 Million-97.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ24.31 B-1,130.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-ยฃ88.32 Million-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA